AMEVIVE's advertisements: problematic?
Katz
Kenneth A
KA
D000329:Advertising / Q000592:standards; D000077944:Alefacept; D004345:Drug Industry; D004346:Drug Information Services; D006801:Humans; D010506:Periodicals as Topic; D011993:Recombinant Fusion Proteins
D011993:Recombinant Fusion Proteins; D000077944:Alefacept